NO853936L - Fremgangsm¨te ved fremstilling av octahydroindolo 2,3-a ki nolizin-1-yl-alkancarboxylsyreamider. - Google Patents

Fremgangsm¨te ved fremstilling av octahydroindolo 2,3-a ki nolizin-1-yl-alkancarboxylsyreamider.

Info

Publication number
NO853936L
NO853936L NO853936A NO853936A NO853936L NO 853936 L NO853936 L NO 853936L NO 853936 A NO853936 A NO 853936A NO 853936 A NO853936 A NO 853936A NO 853936 L NO853936 L NO 853936L
Authority
NO
Norway
Prior art keywords
nolizin
alkancarboxyl
acidamides
octahydroindolo
procedure
Prior art date
Application number
NO853936A
Other languages
English (en)
Other versions
NO161857B (no
Inventor
Ferenc Soti
Csaba Szantay
Maria Incze
Zsuzsanna Balogh
Elemer Ezer
Judit Matuz
Laszlo Szporny
Gyoergy Hajos
Csaba Kuthi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO853936L publication Critical patent/NO853936L/no
Publication of NO161857B publication Critical patent/NO161857B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO853936A 1984-10-05 1985-10-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive octahydroindolo-(2,3-a)-kinolizin-1-yl-alkancarboksylsyreamider og syreaddisjonssalter derav. NO161857B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU843776A HU191454B (en) 1984-10-05 1984-10-05 Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof

Publications (2)

Publication Number Publication Date
NO853936L true NO853936L (no) 1986-04-07
NO161857B NO161857B (no) 1989-06-26

Family

ID=10965440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853936A NO161857B (no) 1984-10-05 1985-10-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive octahydroindolo-(2,3-a)-kinolizin-1-yl-alkancarboksylsyreamider og syreaddisjonssalter derav.

Country Status (23)

Country Link
US (1) US4782052A (no)
EP (1) EP0177361A3 (no)
JP (1) JPS61126086A (no)
KR (1) KR860003254A (no)
CN (1) CN85109716A (no)
AU (1) AU578314B2 (no)
CA (1) CA1267145A (no)
DD (1) DD237659A5 (no)
DK (1) DK453485A (no)
ES (1) ES8701176A1 (no)
FI (1) FI853867L (no)
GR (1) GR852410B (no)
HU (1) HU191454B (no)
IL (1) IL76579A0 (no)
IN (1) IN162609B (no)
NO (1) NO161857B (no)
NZ (1) NZ213710A (no)
PH (1) PH23265A (no)
PL (1) PL145678B1 (no)
PT (1) PT81256B (no)
SU (1) SU1470193A3 (no)
YU (1) YU159085A (no)
ZA (1) ZA857687B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565804A (en) * 1975-10-28 1980-04-23 Inverni Della Beffa Spa Alkaloid derivatives
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
HU178700B (en) * 1978-02-10 1982-06-28 Richter Gedeon Vegyeszet Process for preparing 1,1-disubstituted octahydro-indolo/2,3-a/-quinolizines
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
HU186891B (en) * 1981-06-12 1985-10-28 Richter Gedeon Vegyeszet Process for producing esters of apovincaminic acid
ATE25383T1 (de) * 1981-11-18 1987-02-15 Thal Claude Indoloquinolizinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung.
DE3204960A1 (de) * 1982-02-12 1983-08-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
HU194221B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds

Also Published As

Publication number Publication date
EP0177361A3 (en) 1987-09-02
NZ213710A (en) 1988-08-30
CN85109716A (zh) 1986-10-08
DD237659A5 (de) 1986-07-23
PL255646A1 (en) 1986-10-21
DK453485A (da) 1986-04-06
FI853867A0 (fi) 1985-10-04
PH23265A (en) 1989-06-23
YU159085A (en) 1988-04-30
KR860003254A (ko) 1986-05-21
EP0177361A2 (en) 1986-04-09
NO161857B (no) 1989-06-26
SU1470193A3 (ru) 1989-03-30
PT81256A (en) 1985-11-01
ES8701176A1 (es) 1986-11-16
AU578314B2 (en) 1988-10-20
PL145678B1 (en) 1988-10-31
AU4832985A (en) 1986-04-10
GR852410B (no) 1986-02-04
CA1267145A (en) 1990-03-27
PT81256B (pt) 1987-10-20
US4782052A (en) 1988-11-01
DK453485D0 (da) 1985-10-04
IL76579A0 (en) 1986-02-28
FI853867L (fi) 1986-04-06
ZA857687B (en) 1986-05-28
JPS61126086A (ja) 1986-06-13
IN162609B (no) 1988-06-18
ES547605A0 (es) 1986-11-16
HU191454B (en) 1987-02-27

Similar Documents

Publication Publication Date Title
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
FI853255A0 (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
AR227335A1 (es) Procedimiento para la preparacion de alfa-(3,4,5-trimetoxibenzoiltio)-propionilglicina
NO823183L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO154547C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO853172L (no) Fremgangsmaate for fremstilling av tixotrope vaskemidler.
NO155575C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO853605L (no) Fremgangsm¨te til fremstilling av 2,4-diklor-5-fluor-benzo esyre.
FI852899A0 (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
NO861539L (no) Fremgangsmaate ved fremstilling av (-)-1beta-ethyl-1alfa-hydroxy-methyl-1,2,3,4,6,7,12,12b alfa-octahydroindolo(2,3-a)kinolizin.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO158621C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO853936L (no) Fremgangsm¨te ved fremstilling av octahydroindolo 2,3-a ki nolizin-1-yl-alkancarboxylsyreamider.
NO156863C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
IT8445726A0 (it) Procedimento per la fabbricazione di asciugabiancheria.
NO157450C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO852384L (no) Fremgangsm¨te ved fremstilling av erythropoietin.